Concepedia

Mou Peng

MP

11

Publications

427

Citations

11

H-Index

2015

Active since

Affiliations

Second Xiangya Hospital of Central South University(Current)

Central South University

Albert Einstein College of Medicine

Montefiore Medical Center

Mou Peng is an author at Second Xiangya Hospital of Central South University specializing in cell signaling, tumor biology, and cell biology.

ORCID

Top concepts

Publications per year

2015–2023

11

Publications

11

KIR3DL3-HHLA2 is a human immunosuppressive pathway and a therapeutic target

Wei Yao, Xiaoxin Ren, Phillip M. Galbo et al. · Science Immunology · 2021 · 86 citations · Full text

UBASH3B Is a Novel Prognostic Biomarker and Correlated With Immune Infiltrates in Prostate Cancer

Zijun Wang, Yinhuai Wang, Mou Peng et al. · Frontiers in Oncology · 2020 · 59 citations · Full text

Functional Contribution and Clinical Implication of Cancer-Associated Fibroblasts in Glioblastoma

Phillip M. Galbo, Anne Tranberg Madsen, Yang Liu et al. · Clinical Cancer Research · 2023 · 52 citations · Full text

Blockade of the immunosuppressive KIR2DL5/PVR pathway elicits potent human NK cell–mediated antitumor immunity

Xiaoxin Ren, Mou Peng, Xing Peng et al. · Journal of Clinical Investigation · 2022 · 51 citations · Full text

, , +22

<i>Yap1</i> modulates cardiomyocyte hypertrophy via impaired mitochondrial biogenesis in response to chronic mechanical stress overload

Yue Peng, Yue Zhang, Lei Liu et al. · Theranostics · 2022 · 47 citations · Full text

Rows per page

1–5 of 11